Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk

Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central